Prudential Financial Inc. Sells 46,745 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Prudential Financial Inc. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 56.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,774 shares of the biotechnology company's stock after selling 46,745 shares during the quarter. Prudential Financial Inc.'s holdings in Axon Enterprise were worth $21,856,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Prestige Wealth Management Group LLC grew its position in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock valued at $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise in the fourth quarter valued at about $40,000. Brooklyn Investment Group bought a new position in shares of Axon Enterprise during the 3rd quarter valued at approximately $41,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $45,000. Finally, Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $53,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Remove Ads

Axon Enterprise Price Performance

NASDAQ AXON traded down $9.00 on Monday, hitting $525.95. The stock had a trading volume of 779,068 shares, compared to its average volume of 818,566. The firm has a 50-day moving average of $588.26 and a 200-day moving average of $551.61. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a market capitalization of $40.30 billion, a price-to-earnings ratio of 135.90, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

AXON has been the subject of several research reports. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Needham & Company LLC reaffirmed a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.